Skip to main content
Top
Published in: Reactions Weekly 1/2021

01-11-2021 | Meningitis | Case report

Ipilimumab/nivolumab

Destructive thyroiditis, aseptic meningitis and isolated adrenocorticotropic hormone deficiency: case report

Published in: Reactions Weekly | Issue 1/2021

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Katakura Y, et al. Case Report: A Variety of Immune-Related Adverse Events Triggered by Immune Checkpoint Inhibitors in a Subject With Malignant Melanoma: Destructive Thyroiditis, Aseptic Meningitis and Isolated ACTH Deficiency. Frontiers in Endocrinology 12: Oct 2021. Available from: URL: http://doi.org/10.3389/fendo.2021.722586 Katakura Y, et al. Case Report: A Variety of Immune-Related Adverse Events Triggered by Immune Checkpoint Inhibitors in a Subject With Malignant Melanoma: Destructive Thyroiditis, Aseptic Meningitis and Isolated ACTH Deficiency. Frontiers in Endocrinology 12: Oct 2021. Available from: URL: http://​doi.​org/​10.​3389/​fendo.​2021.​722586
Metadata
Title
Ipilimumab/nivolumab
Destructive thyroiditis, aseptic meningitis and isolated adrenocorticotropic hormone deficiency: case report
Publication date
01-11-2021
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-06167-9

Other articles of this Issue 1/2021

Reactions Weekly 1/2021 Go to the issue

Case report

Antiretrovirals

Case report

Tozinameran